Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma

被引:100
作者
Hillen, Femke [1 ]
Baeten, Coen I. M. [1 ]
van de Winkel, Anouk [1 ]
Creytens, David [1 ]
van der Schaft, Daisy W. J. [1 ]
Winnepenninckx, Veronique [1 ]
Griffioen, Arjan W. [1 ]
机构
[1] Univ Hosp Maastricht, Angiogenesis Lab, Dept Pathol, Res Inst Grow & Dev, NL-6202 AZ Maastricht, Netherlands
关键词
tumor infiltrating leukocytes; prognosis; immunosuppression; activation status of lymphocytes; angiogenesis; tumor cell plasticity; cutaneous melanoma;
D O I
10.1007/s00262-007-0353-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff's (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 79 条
  • [41] Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960
    Levi, F
    Lucchini, F
    Negri, E
    Boyle, P
    La Vecchia, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) : 155 - 169
  • [42] Vascular channel formation by human melanoma cells in vivo and in vitro:: Vasculogenic mimicry
    Maniotis, AJ
    Folberg, R
    Hess, A
    Seftor, EA
    Gardner, LMG
    Pe'er, J
    Trent, JM
    Meltzer, PS
    Hendrix, MJC
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) : 739 - 752
  • [43] THE ORIGIN AND FUNCTION OF TUMOR-ASSOCIATED MACROPHAGES
    MANTOVANI, A
    BOTTAZZI, B
    COLOTTA, F
    SOZZANI, S
    RUCO, L
    [J]. IMMUNOLOGY TODAY, 1992, 13 (07): : 265 - 270
  • [44] Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO
  • [45] 2-Z
  • [46] Changes in the number of CD80+, CD86+, and CD28+ peripheral blood lymphocytes have prognostic value in melanoma patients
    Martínez-Escribano, JA
    Hernández-Caselles, T
    Campillo, JA
    Campos, M
    Frías, JF
    García-Alonso, A
    Alvarez-López, MR
    [J]. HUMAN IMMUNOLOGY, 2003, 64 (08) : 796 - 801
  • [47] THE TRANSFORMING GROWTH-FACTOR-BETA FAMILY
    MASSAGUE, J
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1990, 6 : 597 - 641
  • [48] Rocking the foundations of solid tumor growth by attacking the tumor's blood supply
    Molema, G
    Griffioen, AW
    [J]. IMMUNOLOGY TODAY, 1998, 19 (09): : 392 - 394
  • [49] Cancer regression in patients after transfer of genetically engineered lymphocytes
    Morgan, Richard A.
    Dudley, Mark E.
    Wunderlich, John R.
    Hughes, Marybeth S.
    Yang, James C.
    Sherry, Richard M.
    Royal, Richard E.
    Topalian, Suzanne L.
    Kammula, Udai S.
    Restifo, Nicholas P.
    Zheng, Zhili
    Nahvi, Azam
    de Vries, Christiaan R.
    Rogers-Freezer, Linda J.
    Mavroukakis, Sharon A.
    Rosenberg, Steven A.
    [J]. SCIENCE, 2006, 314 (5796) : 126 - 129
  • [50] Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
    Nair, Smita
    Boczkowski, David
    Fassnacht, Martin
    Pisetsky, David
    Gilboa, Eli
    [J]. CANCER RESEARCH, 2007, 67 (01) : 371 - 380